Market Cap 644.33B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 25.18
Forward PE 23.55
Profit Margin 28.46%
Debt to Equity Ratio 0.44
Volume 6,186,800
Avg Vol 8,082,050
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 71%
Beta 0.24
Analysts Strong Sell
Price Target $275.42

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
Outcomes
Outcomes Aug. 22 at 8:09 PM
$IBRX $MRNA $MRK $PFE $JNJ …..mRNA BAD. Turbo-cancers’ Data. Outcomes. PSS knows. Dr. Kim knows. https://zenodo.org/records/18991296
0 · Reply
TroyTiger
TroyTiger Aug. 22 at 6:58 PM
$TGTX Thanks to a X/Twitter follower I can repost this >> I got it right 2 months ago. Now add $JAZZ, $SNY to $JNJ as possible suitors. >>
1 · Reply
Juhanialainen
Juhanialainen Aug. 22 at 12:09 PM
$SLS You heard it here first: $JNJ is going to buy GPS and $ABBV Tambiciclib. $15 B each. Done deal. Carry on.
USAEquityResearch
USAEquityResearch Aug. 22 at 9:46 AM
$JNJ 📊 USAEquityResearch ▲ 270.24 (+1.07%) Trend: Bullish 📈 RSI (14): 71.6 — overbought, extended, caution warranted MACD: bullish, above signal line and rising Volume: normal 📌 Key Levels Resistance: 273.41 | Support: 254.41 20-MA: 262.15 | 50-MA: 254.83 💼 Fundamentals Mkt Cap: $651.25B P/E (TTM): 31.4 | Fwd P/E: 22.0 FCF: $16.89B (7.01/sh) Total Debt: $49.04B D/E: 57.71 📉 Options (exp 2026-08-28) ATM IV: 24.8% | Skew: +1.0% (balanced) P/C Ratio: 1.05 ⚖️ Neutral Max Pain: 257.50 Call wall: 272.50 | Put wall: 270.00 Educational content only. Not financial advice.
0 · Reply
Gebinator
Gebinator Aug. 21 at 11:43 PM
$SLS Happy weekend to all longs! It's been a beautiful day on Canada's Sunshine Coast 🌞 This week, and today's market activity especially, gives us much optimism that something's afoot and coming down the pipe. If it is the long-awaited '80th event' - well, in many ways it feels to me a relief, but also sadly ironic the 80th REGAL patient's death will cause such excitement and action in the stock market. For this reason I used to hold a lot of resentment for the IDMC for not halting and unblinding REGAL sooner. But I've resigned to waiting on the 80th like everyone else, having faith that the REGAL FA will show extraordinary efficacy, statistical power, meaning and significance and that, in of itself, will help save and extend more lives over the long term. Those BPs in the running - $JNJ, $LLY, $ABBV, $MRK, etc. -- I'm sure they all want REGAL numbers and statistics as refined, unequivocal and significant as possible -- and that will benefit all parties concerned! Reminder 👇
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 21 at 11:10 PM
$SLS Dr. Stergiou is a very Shrewd CEO. He/Sellas didn’t go in to a quiet period on July 7, 2026 if it was that far ought. Dr. Stergiou is a man with a master plan, Monday is a going to rude awakening for Shorts that has been talking trash about him for years. News will hit in waves and by EOM September 2026 Sellas won’t be a stand alone Co. but be part of $JNJ. Mark this post! ✌️🙏❤️‍🩹
0 · Reply
Outcomes
Outcomes Aug. 21 at 10:58 PM
$IBRX $MRNA $MRK $PFE $JNJ mRNA BAD. Covid jab: ‘Turbo-cancers’ Flu vax: botched trial PSS knows. https://x.com/jesslovesmjk/status/2090478010600218827?s=46
1 · Reply
Ryuk
Ryuk Aug. 21 at 10:28 PM
$JNJ $1.88 close. You're welcome.
0 · Reply
trachea
trachea Aug. 21 at 7:58 PM
$JNJ $SLS are you ok bro?👍😁🍀
0 · Reply
Johnmtnb2018
Johnmtnb2018 Aug. 21 at 7:58 PM
$SLS $JNJ BO Monday!
0 · Reply
Latest News on JNJ
Johnson & Johnson Transcript: Investor update

Aug 3, 2026, 8:00 AM EDT - 19 days ago

Johnson & Johnson Transcript: Investor update


Inside J&J's Lab to Create a Simpler Robotic Surgery Device

Aug 2, 2026, 8:00 AM EDT - 20 days ago

Inside J&J's Lab to Create a Simpler Robotic Surgery Device


Johnson & Johnson lowers 2026 profit forecast

Jul 29, 2026, 5:38 PM EDT - 23 days ago

Johnson & Johnson lowers 2026 profit forecast


Explainer: Can J&J finally put the talc litigation behind it?

Jul 29, 2026, 12:01 PM EDT - 24 days ago

Explainer: Can J&J finally put the talc litigation behind it?


Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits

Jul 28, 2026, 12:26 PM EDT - 25 days ago

Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits


J&J offers $5.5bn to settle baby powder lawsuits

Jul 28, 2026, 12:31 AM EDT - 25 days ago

J&J offers $5.5bn to settle baby powder lawsuits


DePuy Synthes Acquires Expanding Innovations™

Jul 16, 2026, 8:00 AM EDT - 5 weeks ago

DePuy Synthes Acquires Expanding Innovations™


Johnson & Johnson Earnings Call Transcript: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 5 weeks ago

Johnson & Johnson Earnings Call Transcript: Q2 2026


Johnson & Johnson Slides: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 5 weeks ago

Johnson & Johnson Slides: Q2 2026


Johnson & Johnson Earnings release: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 5 weeks ago

Johnson & Johnson Earnings release: Q2 2026


Johnson & Johnson Quarterly report: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 5 weeks ago

Johnson & Johnson Quarterly report: Q2 2026


Johnson & Johnson Hikes Guidance, Stock Falls

Jul 15, 2026, 6:35 AM EDT - 5 weeks ago

Johnson & Johnson Hikes Guidance, Stock Falls


Johnson & Johnson Bumps Up Guidance as Sales Rise

Jul 15, 2026, 6:33 AM EDT - 5 weeks ago

Johnson & Johnson Bumps Up Guidance as Sales Rise


Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

Jul 15, 2026, 6:20 AM EDT - 5 weeks ago

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook


The Big 3: UNH, KO, JNJ

Jul 9, 2026, 1:00 PM EDT - 6 weeks ago

The Big 3: UNH, KO, JNJ

KO UNH


Johnson & Johnson to Buy Firefly Bio for $1 Billion

Jun 8, 2026, 9:01 AM EDT - 2 months ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion


Outcomes
Outcomes Aug. 22 at 8:09 PM
$IBRX $MRNA $MRK $PFE $JNJ …..mRNA BAD. Turbo-cancers’ Data. Outcomes. PSS knows. Dr. Kim knows. https://zenodo.org/records/18991296
0 · Reply
TroyTiger
TroyTiger Aug. 22 at 6:58 PM
$TGTX Thanks to a X/Twitter follower I can repost this >> I got it right 2 months ago. Now add $JAZZ, $SNY to $JNJ as possible suitors. >>
1 · Reply
Juhanialainen
Juhanialainen Aug. 22 at 12:09 PM
$SLS You heard it here first: $JNJ is going to buy GPS and $ABBV Tambiciclib. $15 B each. Done deal. Carry on.
USAEquityResearch
USAEquityResearch Aug. 22 at 9:46 AM
$JNJ 📊 USAEquityResearch ▲ 270.24 (+1.07%) Trend: Bullish 📈 RSI (14): 71.6 — overbought, extended, caution warranted MACD: bullish, above signal line and rising Volume: normal 📌 Key Levels Resistance: 273.41 | Support: 254.41 20-MA: 262.15 | 50-MA: 254.83 💼 Fundamentals Mkt Cap: $651.25B P/E (TTM): 31.4 | Fwd P/E: 22.0 FCF: $16.89B (7.01/sh) Total Debt: $49.04B D/E: 57.71 📉 Options (exp 2026-08-28) ATM IV: 24.8% | Skew: +1.0% (balanced) P/C Ratio: 1.05 ⚖️ Neutral Max Pain: 257.50 Call wall: 272.50 | Put wall: 270.00 Educational content only. Not financial advice.
0 · Reply
Gebinator
Gebinator Aug. 21 at 11:43 PM
$SLS Happy weekend to all longs! It's been a beautiful day on Canada's Sunshine Coast 🌞 This week, and today's market activity especially, gives us much optimism that something's afoot and coming down the pipe. If it is the long-awaited '80th event' - well, in many ways it feels to me a relief, but also sadly ironic the 80th REGAL patient's death will cause such excitement and action in the stock market. For this reason I used to hold a lot of resentment for the IDMC for not halting and unblinding REGAL sooner. But I've resigned to waiting on the 80th like everyone else, having faith that the REGAL FA will show extraordinary efficacy, statistical power, meaning and significance and that, in of itself, will help save and extend more lives over the long term. Those BPs in the running - $JNJ, $LLY, $ABBV, $MRK, etc. -- I'm sure they all want REGAL numbers and statistics as refined, unequivocal and significant as possible -- and that will benefit all parties concerned! Reminder 👇
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 21 at 11:10 PM
$SLS Dr. Stergiou is a very Shrewd CEO. He/Sellas didn’t go in to a quiet period on July 7, 2026 if it was that far ought. Dr. Stergiou is a man with a master plan, Monday is a going to rude awakening for Shorts that has been talking trash about him for years. News will hit in waves and by EOM September 2026 Sellas won’t be a stand alone Co. but be part of $JNJ. Mark this post! ✌️🙏❤️‍🩹
0 · Reply
Outcomes
Outcomes Aug. 21 at 10:58 PM
$IBRX $MRNA $MRK $PFE $JNJ mRNA BAD. Covid jab: ‘Turbo-cancers’ Flu vax: botched trial PSS knows. https://x.com/jesslovesmjk/status/2090478010600218827?s=46
1 · Reply
Ryuk
Ryuk Aug. 21 at 10:28 PM
$JNJ $1.88 close. You're welcome.
0 · Reply
trachea
trachea Aug. 21 at 7:58 PM
$JNJ $SLS are you ok bro?👍😁🍀
0 · Reply
Johnmtnb2018
Johnmtnb2018 Aug. 21 at 7:58 PM
$SLS $JNJ BO Monday!
0 · Reply
DidYouReadThis
DidYouReadThis Aug. 21 at 7:52 PM
2 heads are better than one? Care to make a guess for me to point out what I might be missing about #otlk? $MRNA $REGN $JNJ $SLS . Thank you all!
0 · Reply
Ryuk
Ryuk Aug. 21 at 5:21 PM
$JNJ $1.70
0 · Reply
Ryuk
Ryuk Aug. 21 at 4:24 PM
$JNJ $1.58
0 · Reply
TheChartiste
TheChartiste Aug. 21 at 4:12 PM
$JNJ steady climber from here
0 · Reply
Ryuk
Ryuk Aug. 21 at 3:28 PM
$JNJ $1.45
0 · Reply
Ryuk
Ryuk Aug. 21 at 3:26 PM
$JNJ Lotto Play: $270 puts at $0.33.
0 · Reply
Ryuk
Ryuk Aug. 21 at 3:19 PM
$JNJ Lotto Play: $272.50 puts at $1.25.
0 · Reply
cykuTYTkaxa
cykuTYTkaxa Aug. 21 at 3:04 PM
$JNJ + 3D Systems https://www.reddit.com/r/DDDInvestors/s/gxhrQpL6eH
0 · Reply
NEWBIGTECH
NEWBIGTECH Aug. 21 at 2:28 PM
$SLS from x. $JNJ Updated website on Aug 17, 2026.
0 · Reply
GordoHLYK13
GordoHLYK13 Aug. 21 at 1:11 PM
$IGC is already in Phase 2 CALMA—this isn’t a preclinical story. If the Phase 2 topline confirms the encouraging interim efficacy and safety signals, IGC could go from overlooked micro-cap to a serious Big Pharma target for partnership, licensing, or acquisition discussions. 🚀 Phase 2 success changes the game. Big Pharma doesn’t chase potential—it chases validated clinical data. If CALMA delivers, don’t be surprised when the big boys start chasing $MRNA $LLY $JNJ
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 21 at 12:16 PM
$JNJ $SLS Part 5. Dr. Stergiou can’t send a more blunt signal than this “SELLAS Life Sciences Group, Inc. entered a quiet period regarding any clinical updates and other corporate matters with investors and shareholders.” Other Corporate matters include M&A! ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 21 at 12:00 PM
$JNJ $SLS Part 4. Mr. Cavanaugh takes over On 9/1/26 that’s 6 trading days from today. Expecting 1 major PR before that. Stay Tuned things are about to get very interesting! ✌️🙏❤️‍🩹
0 · Reply